T1	Disease	69 97	EGFR -mutated NSCLC patients
T2	Gene_or_protein	118 127	EGFR -TKI
T3	Chemical	118 132	EGFR -TKI used
T4	Chemical	322 333	itinib rech
T5	Disease	350 372	mutated NSCLC patients
T6	Chemical	410 466	I followed by a subsequent line of treatment ( excluding
T7	Chemical	475 481	Is ) .
R1	treats	Arg1:T1	Arg2:T5
R2	treats	Arg1:T2	Arg2:T1
R3	influences	Arg1:T2	Arg2:T3
R4	influences	Arg1:T2	Arg2:T4
R5	treats	Arg1:T2	Arg2:T5
R6	treats	Arg1:T2	Arg2:T6
R7	treats	Arg1:T2	Arg2:T7
R8	treats	Arg1:T3	Arg2:T1
R9	influences	Arg1:T3	Arg2:T2
R10	influences	Arg1:T3	Arg2:T4
R11	treats	Arg1:T3	Arg2:T5
R12	treats	Arg1:T3	Arg2:T7
R13	treats	Arg1:T4	Arg2:T1
R14	influences	Arg1:T4	Arg2:T2
R15	influences	Arg1:T4	Arg2:T3
R16	treats	Arg1:T4	Arg2:T5
R17	influences	Arg1:T4	Arg2:T6
R18	treats	Arg1:T5	Arg2:T1
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
R21	isAssociatedWith	Arg1:T5	Arg2:T6
R22	isAssociatedWith	Arg1:T5	Arg2:T7
R23	treats	Arg1:T6	Arg2:T1
R24	influences	Arg1:T6	Arg2:T2
R25	influences	Arg1:T6	Arg2:T3
R26	influences	Arg1:T6	Arg2:T4
R27	treats	Arg1:T6	Arg2:T5
R28	treats	Arg1:T6	Arg2:T7
R29	treats	Arg1:T7	Arg2:T1
R30	influences	Arg1:T7	Arg2:T2
R31	influences	Arg1:T7	Arg2:T3
R32	influences	Arg1:T7	Arg2:T4
R33	treats	Arg1:T7	Arg2:T5
R34	influences	Arg1:T7	Arg2:T6
